SELL
₹979
₹1,110
₹900
8.07%
Emkay Research’s August 26, 2026 analyst-meet update says Cyient’s management has addressed the primary impediments to growth through a more coherent strategy and has identified operating levers. However, Emkay retains its REDUCE rating because a change in stance depends on execution.
The broker retains its sum-of-the-parts-based target price of Rs 900 for June 2027, versus a current market price of Rs 979, implying 8.1 per cent downside.
Cyient is seeking to move beyond niche engineering research and development services towards Whole Asset Lifecycle Engineering. Management aims to participate in all nine stages of the asset lifecycle, compared with the three to four stages traditionally addressed by engineering research and development outsourcing.
Cyient already has design exposure in 76 per cent of accounts, service exposure in 58 per cent and manufacturing exposure in 35 per cent. Emkay sees the gap in penetration across lifecycle stages as a wallet-share opportunity within existing accounts, which could reduce reliance on new-logo wins. The addressable market is expected to expand from about US dollar 80–100 billion in core engineering to US dollar 2.4–3.2 trillion across the broader lifecycle.
Management aims to scale lifecycle engineering and higher-value, annuity-led services to create a more predictable and faster-growing revenue mix. Its medium-term aspirations include:
The report notes that enterprise artificial intelligence adoption is constrained by fragmented data and legacy systems rather than insufficient computing capacity. This makes data contextualisation and integration important areas where Cyient’s engineering and domain context could be relevant.
Two acquisitions are expected to reshape Cyient’s growth from FY27:
Following consolidation, the acquisitions are intended to lift group revenue to US dollar 1 billion.
Cyient Semiconductors is targeting approximately fourfold revenue growth by FY31 from a current run rate of US dollar 65 million, including Kinetic. Management targets gross margin above 40 per cent, research and development spending of about 20 per cent of revenue and EBIT margin above 20 per cent.
The business has two product lines:
The focus is on analog integrated circuits, particularly power and sensing. Recent developments include an exclusive Navitas partnership for gallium-nitride power integrated circuits, three patents filed, Open Compute Project membership, selection for the 180nm fab-modernisation project in Mohali and a strategic partnership with GlobalFoundries.
Emkay’s estimates are as follows:
| Metric | FY27E | FY28E | FY29E |
|---|---|---|---|
| Consolidated revenue (Rs million) | 85,497 | — | — |
| Revenue growth | 17.6% from FY26 | — | — |
| EBITDA (Rs million) | 11,232 | — | — |
| Adjusted PAT (Rs million) | 5,141 | — | — |
| EBITDA margin | 13.1% | 14.3% | 14.7% |
The principal investment-case risk identified by Emkay is execution. The strategy, acquisitions, lifecycle cross-selling and semiconductor ambitions must translate into the targeted growth and profitability before the broker would reconsider its rating.
Management’s capital-allocation guardrails include:
| Area | Guardrail |
|---|---|
| Working capital | 40–45 days |
| Capex intensity | 1–1.5 per cent |
| Sales and technology investment | 0.5–1 per cent |
| Acquisition investments | Limited to one year of free cash flow, with return on invested capital above 15 per cent |
| Leverage | Within 0.5 times |
| Payout | Up to 50 per cent of PAT, with an optional buyback |
Disclaimer: This is a summary of a research report published by the broker/research house identified above. The views, recommendations, target prices and estimates are those of the respective broker and do not represent DSIJ investment advice. The summary may be AI-assisted, hence please refer to the original report for complete details, disclosures and risks.
Copyright 2026 by DSIJ Wealth Advisory Pvt. Ltd. (Formerly Known as DSIJ Pvt. Ltd.)